BSE Live
Oct 08, 16:01Prev. Close
1654.30
Open Price
1645.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 08, 15:57Prev. Close
1653.10
Open Price
1645.00
Bid Price (Qty.)
1633.20 (334)
Offer Price (Qty.)
1633.30 (176)
Cash Flow of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 5,030.57 | 3,449.65 | 1,741.05 | 306.86 | 2,152.87 | |
Net CashFlow From Operating Activities | 4,198.77 | -292.42 | 507.08 | 7,636.36 | 1,737.25 | |
Net Cash Used In Investing Activities | -209.56 | -262.91 | -705.17 | -2,702.10 | -601.80 | |
Net Cash Used From Financing Activities | -3,831.18 | 473.95 | 169.31 | -4,870.85 | -1,126.29 | |
Foreign Exchange Gains / Losses | 7.53 | -2.44 | 19.53 | 5.06 | -7.32 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 165.56 | -83.82 | -9.25 | 68.47 | 1.84 | |
Cash And Cash Equivalents Begin of Year | 326.46 | 410.28 | 419.53 | 351.06 | 220.50 | |
Cash And Cash Equivalents End Of Year | 492.02 | 326.46 | 410.28 | 419.53 | 222.34 |
10.09.2025
07.08.2025
04.08.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875: Prabhudas Lilladher
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend
01.02.2025
Sun Pharma Consolidated December 2024 Net Sales at Rs 13,675.46 crore, up 10.46% Y-o-Y